Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar 12;371(6534):1154-1159.
doi: 10.1126/science.abd0919.

Debaryomyces is enriched in Crohn's disease intestinal tissue and impairs healing in mice

Umang Jain  1 , Aaron M Ver Heul  1   2 , Shanshan Xiong  1 , Martin H Gregory  2 , Elora G Demers  3 , Justin T Kern  1 , Chin-Wen Lai  1   4 , Brian D Muegge  1   2   5 , Derek A G Barisas  1 , J Steven Leal-Ekman  1 , Parakkal Deepak  2 , Matthew A Ciorba  2 , Ta-Chiang Liu  1 , Deborah A Hogan  3 , Philip Debbas  6 , Jonathan Braun  6 , Dermot P B McGovern  6   7 , David M Underhill  6   7 , Thaddeus S Stappenbeck  8   9
Affiliations

Debaryomyces is enriched in Crohn's disease intestinal tissue and impairs healing in mice

Umang Jain et al. Science. .

Abstract

Alterations of the mycobiota composition associated with Crohn's disease (CD) are challenging to link to defining elements of pathophysiology, such as poor injury repair. Using culture-dependent and -independent methods, we discovered that Debaryomyces hansenii preferentially localized to and was abundant within incompletely healed intestinal wounds of mice and inflamed mucosal tissues of CD human subjects. D. hansenii cultures from injured mice and inflamed CD tissues impaired colonic healing when introduced into injured conventionally raised or gnotobiotic mice. We reisolated D. hansenii from injured areas of these mice, fulfilling Koch's postulates. Mechanistically, D. hansenii impaired mucosal healing through the myeloid cell-specific type 1 interferon-CCL5 axis. Taken together, we have identified a fungus that inhabits inflamed CD tissue and can lead to dysregulated mucosal healing.

PubMed Disclaimer

Conflict of interest statement

Competing interests: U.J. and T.S.S. are co-inventors on the patent application (PCT/US2020/064376). P.Dee. has served as a consultant or advisory board member for Janssen, Pfizer, Celgene, Arena, and Prometheus and has received research grants from Takeda. All other authors declare no conflict of interest.

Figures

Fig. 1.
Fig. 1.. Broad-spectrum antibiotic–mediated inhibition of colonic crypt regeneration was reversed by treatment with amphotericin B.
(A and B) WT mice were pretreated for 4 weeks with antibiotics (VNAM) or vehicle, biopsy injured, and analyzed at day 12 after injury. Representative hematoxylin and eosin (H&E) images (A) and wound bed lengths (B) are shown (n = 11 to 17 wounds per group; seven or eight mice per group). (C and D) VNAM-pretreated mice were biopsy injured and treated with NS-398 (PGE2 synthesis inhibitor) or vehicle (control) twice daily from days 4 to 10 after injury. Representative H&E images (C) and wound bed lengths (D) are shown (n = 11 to 12 wounds per group; five mice per group) at day 12 after injury. (E and F) VNAM-pretreated mice were administered amphotericin B (AmpB) or vehicle (control) and then biopsy injured. Representative H&E images (E) and wound bed lengths (n = 12 or 13 wounds per group; five to seven mice per group) at day 12 after injury are shown. Significance (unpaired Student’s t test): ****P < 0.0001; N.S., not significant. All values in (B), (D), and (F) are means ± SEM. Dashed black lines in (A), (C), and (E) represent wound bed lengths (largest distance between the crypts). Scale bars, 100 μm.
Fig. 2.
Fig. 2.. Debaryomyces was enriched in wounds of VNAM-pretreated mice; its administration to conventionally raised or gnotobiotic mice led to impaired crypt regeneration.
(A to E) WT mice, pretreated for 4 weeks with VNAM or Kool-Aid (control), were biopsy injured and wounds were analyzed at day 8 after injury. A schematic representation (A) and relative abundance of fungi in the wounds (B) are shown. C, control; V, VNAM treated. The representative cultures (C) and counts of viable colonies (D) are for 14 to 16 wounds per group with four to six mice per group. Significance (unpaired Student’s t test): **P < 0.01. In (E), we show the identification of fungi by ITS sequencing of the pooled colonies per mouse in (C). (F to H) WT mice gavaged with phosphate-buffered saline (PBS; controls), D. hansenii (B6A1), or S. cerevisiae were biopsy injured and wounds were analyzed at day (d) 12 after injury. The experimental scheme (F), representative H&E images (G), and wound bed lengths are shown for 13 to 19 wounds per group with six to eight mice per group. (I to K) WT mice were gavaged with PBS (control), D. hansenii, or C. tropicalis and analyzed after DSS recovery. The experimental setup (I), representative H&E images (J), and percent colonic crypt loss (n = five to seven mice per group) are shown. Significance [one-way analysis of variance (ANOVA) and Tukey’s post hoc test]: ****P < 0.0001. All values in (D), (H), and (K) are means ± SEM. Dashed black line in (G) represents wound bed length. Scale bars, 100 μm.
Fig. 3.
Fig. 3.. D. hansenii impairs crypt regeneration through type I IFN and CCL5.
(A) Representative plots of live cells isolated from mouse colons after DSS recovery. (B) Cells from (A) were lysed and cultured on SDA (n = 4 to 6 mice per group). Significance (two-way ANOVA with Tukey’s post hoc test): ***P < 0.001. (C) Fold change in D. hansenii–infected wounds (black circles) or macrophages (blue circles) compared with respective controls. (D and E) Representative H&E images (D) and wound bed lengths (E) at day 12 after injury (n = 12 to 17 wounds per group; five to seven mice per group) in Ccl5−/− and WT mice gavaged with D. hansenii (B6A1). Significance (unpaired Student’s t test): ****P < 0.0001. (F) Percent colonic crypt loss in mice after DSS recovery in the absence or presence of D. hansenii (n = 6 mice per group). Significance (two-way ANOVA and Tukey’s post hoc test): **P < 0.01. (G) CCL5 in BMDM supernatant 24 hours after D. hansenii stimulation (n = four experiments). N.D., not detected. (H and I) Representative H&E images (H) and wound bed lengths (I) at day 12 after injury (n = 16 wounds; six to seven mice per group) in mice gavaged or not with D. hansenii as indicated. Significance (unpaired Student’s t test): ****P < 0.0001. (J) CCL5 in BMDM supernatant 24 hours after D. hansenii stimulation (n = 4 experiments). Significance (unpaired Student’s t test): ****P < 0.0001. (K and L) Representative H&E images (K) and percent colonic crypt loss (L) in LysMCre Stat1fl/fl and Stat1fl/fl mice after DSS recovery in the presence of D.hansenii (n = 6 to 10 mice per group). Significance (unpaired Student’s t test): ****P < 0.0001. All values in (B), (E), (F), (G), (I), (J), and (L) are means ± SEM. Dashed black lines in (D) and (H) represent wound bed lengths. Scale bars, 100 μm.
Fig. 4.
Fig. 4.. D. hansenii was enriched in inflamed intestinal tissue of patients with CD, and the human isolate impaired crypt regeneration in vivo.
(A and B) Ileal biopsy tissue from healthy individuals and CD patients, cultured on SDA, shown in a schematic representation (A) and as the relative abundance of fungi assessed by ITS sequencing of the pooled colonies for each individual (B). (C and D) ITS sequencing of DNA isolated from inflamed and noninflamed ileal regions of CD surgical resections, as shown in a schematic representation (C) and as the relative abundance of fungi (D). Only genera with a combined mean across both groups of >1.5% relative abundance are plotted. All other genera are combined into “Other.” (E) Relative fungal abundance of colonies cultured from the surgical resections in (C). (F) D. hansenii abundance was analyzed by qPCR and normalized to human Gapdh DNA. Significance (paired Student’s t test): *P < 0.05; **P < 0.01. WU, Washington University; CS, Cedars-Sinai. (G to I) WT mice were gavaged with D. hansenii (CDA1) in the presence or absence of amphotericin B (AmpB) and biopsy injured. A schematic representation (G), representative H&E images (H), and wound bed lengths (I) at day 12 after injury are shown (n = 14 to 17 wounds per group; five to seven mice per group). Significance (one-way ANOVA and Tukey’s post hoc test): ****P < 0.0001. All values in (I) are means ± SEM. The dashed black line in (H) represents the wound bed. Scale bars, 100 μm.
See this image and copyright information in PMC

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Neurath MF, Mucosal Immunol 7, 6–19 (2014). - PubMed
    1. Schirmer M, Garner A, Vlamakis H, Xavier RJ, Nat. Rev. Microbiol 17, 497–511 (2019). - PMC - PubMed
    1. Lavelle A, Sokol H, Nat. Rev. Gastroenterol. Hepatol 17, 223–237 (2020). - PubMed
    1. Lloyd-Price J et al., Nature 569, 655–662 (2019). - PMC - PubMed
    1. Sun L, Nava GM, Stappenbeck TS, Curr. Opin. Gastroenterol 27, 321–327 (2011). - PMC - PubMed

Publication types

MeSH terms